PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Super-Vaccine targets 24 strains of child pneumonia in first human tests
⭐️ VACCINE ⭐️ OngoingThis is an early safety study testing a new pneumonia vaccine designed to protect against 24 different strains of the bacteria. It will involve 230 healthy children and teenagers, aged from 6 weeks to 17 years old. The main goal is to check if the vaccine is safe and to see how w…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 13, 2026 15:05 UTC
-
New vaccine aims to broaden protection against Pneumonia-Causing bacteria
⭐️ VACCINE ⭐️ OngoingThis study is testing a new vaccine designed to protect against 24 strains of pneumococcal bacteria, which can cause pneumonia and other serious infections. It will involve 992 healthy Chinese adults aged 18 and older to see how safe the vaccine is and how well it triggers an imm…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 09, 2026 14:23 UTC